Citadel Advisors’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Citadel Advisors’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-69,600	Closed	-$2.49M	–	9236
2014 Q4	$2.49M	Sell	69,600 -20,900	-23%	-$624K	﹤0.01%	2661
2014 Q3	$2.35M	Buy	90,500 +39,700	+78%	+$1.14M	﹤0.01%	2670
2014 Q2	$1.68M	Buy	50,800 +18,100	+55%	+$523K	﹤0.01%	2914
2014 Q1	$979K	Sell	32,700 -21,800	-40%	-$751K	﹤0.01%	3456
2013 Q4	$1.66M	Sell	54,500 -7,000	-11%	-$193K	﹤0.01%	2732
2013 Q3	$1.96M	Buy	61,500 +4,600	+8%	+$106K	﹤0.01%	2432
2013 Q2	$859K	Buy	+56,900	New	+$788K	﹤0.01%	3330

Other funds holding NPSP

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citadel Advisors's NPSP Position: Q4 2014 in Review

Citadel Advisors sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2014, closing a stake of 47,731 shares — an estimated $1.42M sold.

Citadel Advisors first reported a position in NPSP in Q2 2013 and held it in 6 quarters. The position peaked at $10.7M in Q1 2014. 213 funds tracked by Wall St. Rank hold NPSP as of Q4 2014.

Citadel Advisors reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
Citadel Advisors sold 47,731 NPS PHARMACEUTICALS INC shares in Q4 2014, an estimated $1.42M.
Citadel Advisors first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
Citadel Advisors's NPS PHARMACEUTICALS INC position peaked at $10.7M in Q1 2014.
213 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.